Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Beyza Olcay Ozturk"'
Autor:
Gulsah Elbuken, Cihan Aydin, Beyza Olcay Ozturk, Huseyin Aykac, Birol Topcu, Sayid Shafi Zuhur
Publikováno v:
Endokrynologia Polska. 74:67-73
Introduction: Normocalcaemic hyperparathyroidism is a condition first defined in 2008, characterized by normal se- rum calcium and high parathormone levels. Although normocalcaemic hyperparathyroidism is considered to have a milder clinical picture c
Publikováno v:
JCEM Case Reports. 1
Introduction Neurofibromatosis type-1 (NF-1) is an autosomal dominant genetic disorder. It is associated with the development of café-au-lait macules, axillary and/or inguinal frecklings, Lisch nodules, hypertension, osteoporosis, skeletal abnormali
Autor:
Nuh Atas, Gulsah Atbiner Eroglu, Hulya Nur Sodan, Beyza Olcay Ozturk, Hakan Babaoglu, Hasan Satis, Hazan Karadeniz, Aslihan Avanoglu Guler, Reyhan Bilici Salman, Berna Goker, Mehmet Akif Ozturk, Seminur Haznedaroglu, Abdurrahman Tufan
Publikováno v:
Clinical and Experimental Rheumatology. 39:30-36
Anakinra and canakinumab are the most commonly used agents in colchicine resistant/intolerant patients. In this study we investigated long-term efficacy and safety of anakinra and canakinumab.In this retrospective study, we enrolled 101 adult patient
Publikováno v:
JCEM Case Reports. 2023 Supplement, Vol. 1, pA1-A37. 104p.
Autor:
Zuhur, Sayid Shafi, Aggul, Hunkar, Avci, Ugur, Erol, Selvinaz, Tuna, Mazhar Muslum, Uysal, Serhat, Akbaba, Gulhan, Kilinc, Faruk, Catak, Merve, Tekin, Sakin, Ozturk, Beyza Olcay, Yavuz, Halise Cinar, Kadioglu, Pinar, Cinar, Nese, Bayraktaroglu, Taner, Topcu, Birol, Altuntas, Yuksel, Elbuken, Gulsah
Publikováno v:
Endocrine (1355008X); Mar2024, Vol. 83 Issue 3, p700-707, 8p
Autor:
Elbuken, Gulsah, Aydin, Cihan, Ozturk, Beyza Olcay, Aykac, Huseyin, Topcu, Birol, Zuhur, Sayid Shafi
Publikováno v:
Polish Journal of Endocrinology / Endokrynologia Polska; 2023, Vol. 74 Issue 1, p67-73, 7p
Publikováno v:
Health & Medicine Week; 3/3/2023, p5514-5514, 1p
Publikováno v:
Medical Devices & Surgical Technology Week; 2/19/2023, p1874-1874, 1p